Search Clinical Trials
589,279 trials
ID
Status
Phase
Title
Sponsor
NCT07647107
A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy PopulationsDr Cipto Mangunkusumo General HospitalNot Yet RecruitingPhase 1
NCT07647107Not Yet Recruiting
Phase 1
A Phase I Study of Lipovaxin Tuberculosis Vaccine in Adult Healthy PopulationsDr Cipto Mangunkusumo Gen...
NCT07648316
Effects of Red Panax Ginseng Supplementation on Cognitive Performance and Emotional Well-Being in Young Healthy AdultsArizona State UniversityNot Yet RecruitingNot Applicable
NCT07648316Not Yet Recruiting
Not Applicable
Effects of Red Panax Ginseng Supplementation on Cognitive Performance and Emotio...Arizona State University
NCT07648186
Preventive Exercise Program for Adolescent Futsal Players.University of MalagaNot Yet RecruitingNot Applicable
NCT07648186Not Yet Recruiting
Not Applicable
Preventive Exercise Program for Adolescent Futsal Players.University of Malaga
NCT07647289
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBCJiangsu Provincial People's HospitalRecruitingPhase 2
NCT07647289Recruiting
Phase 2
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBCJiangsu Provincial People...
NCT07647770
The Impact of Ventilator Synchrony on Muscle Relaxant Consumption and Surgeon Satisfaction During Laparoscopic Cholecystectomy.Hitham Mohammed Aly ElsayedNot Yet RecruitingNot Applicable
NCT07647770Not Yet Recruiting
Not Applicable
The Impact of Ventilator Synchrony on Muscle Relaxant Consumption and Surgeon Sa...Hitham Mohammed Aly Elsay...
NCT07647614
A Phase II Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for Parkinson's DiseaseEnergenesis Biomedical Co., Ltd.Not Yet RecruitingPhase 2
NCT07647614Not Yet Recruiting
Phase 2
A Phase II Study to Evaluate the Efficacy and Safety of ENERGI-F705 Tablets for...Energenesis Biomedical Co...
NCT07647653
Fluzoparib + Bevacizumab vs Olaparib + Bevacizumab for Maintenance Therapy in HRD-Positive Advanced Ovarian CancerShandong UniversityNot Yet RecruitingPhase 2
NCT07647653Not Yet Recruiting
Phase 2
Fluzoparib + Bevacizumab vs Olaparib + Bevacizumab for Maintenance Therapy in HR...Shandong University
NCT07647887
Effects of Cervical Manual Therapy for Temporomandibular Disorders With MyalgiaNational Yang Ming Chiao Tung UniversityNot Yet RecruitingNot Applicable
NCT07647887Not Yet Recruiting
Not Applicable
Effects of Cervical Manual Therapy for Temporomandibular Disorders With MyalgiaNational Yang Ming Chiao...
NCT07647484
Peripheral Blood CyTOF and Viral Imprinting in Postoperative Multiple Pulmonary NodulesThe First Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07647484Not Yet Recruiting
—
Peripheral Blood CyTOF and Viral Imprinting in Postoperative Multiple Pulmonary...The First Affiliated Hosp...
NCT07646756
Longitudinal Evaluation of Preoperative eHealth Literacy and Nutritional Index on Early Functional Recovery After Fragility FracturesShandong UniversityCompleted
NCT07646756Completed
—
Longitudinal Evaluation of Preoperative eHealth Literacy and Nutritional Index o...Shandong University
NCT07648524
Influence of Cardiopulmonary Rehabilitation on Cardiorespiratory Adaptation in Patients With Pulmonary HypertensionCairo UniversityNot Yet RecruitingNot Applicable
NCT07648524Not Yet Recruiting
Not Applicable
Influence of Cardiopulmonary Rehabilitation on Cardiorespiratory Adaptation in P...Cairo University
NCT07648641
A Clinical Trial of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)CanSino Biologics Inc.Not Yet Recruiting
NCT07648641Not Yet Recruiting
—
A Clinical Trial of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine...CanSino Biologics Inc.
NCT07647861
Efficacy of Lasers, Propolis-Based Agent, and Sham for Dentine HypersensitivityOndokuz Mayıs UniversityCompletedNot Applicable
NCT07647861Completed
Not Applicable
Efficacy of Lasers, Propolis-Based Agent, and Sham for Dentine HypersensitivityOndokuz Mayıs University
NCT07647419
Aromatherapy and Music Therapy for Anxiety Management During Mandibular Third Molar ExtractionUniversidad Científica del SurCompletedNot Applicable
NCT07647419Completed
Not Applicable
Aromatherapy and Music Therapy for Anxiety Management During Mandibular Third Mo...Universidad Científica de...
NCT07647341
Breathwork Training Reduces Anxiety In Outpatient Gastrointestinal ProceduresCalm and Sense Technologies LLCCompletedNot Applicable
NCT07647341Completed
Not Applicable
Breathwork Training Reduces Anxiety In Outpatient Gastrointestinal ProceduresCalm and Sense Technologi...
NCT07647991
The IGBallon (R) - for Use in the Treatment of ObesityMedical University of ViennaCompletedNot Applicable
NCT07647991Completed
Not Applicable
The IGBallon (R) - for Use in the Treatment of ObesityMedical University of Vie...
NCT07647458
Quantifying Adhesive Residue on Skin Following Removal of Maxillofacial Prosthetic Adhesives: An In Vivo StudyAmrita Vishwa VidyapeethamCompletedNot Applicable
NCT07647458Completed
Not Applicable
Quantifying Adhesive Residue on Skin Following Removal of Maxillofacial Prosthet...Amrita Vishwa Vidyapeetha...
NCT07646639
Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARCThe First Affiliated Hospital with Nanjing Medical UniversityRecruitingPhase 2
NCT07646639Recruiting
Phase 2
Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARCThe First Affiliated Hosp...
NCT07646678
A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaTakedaNot Yet RecruitingPhase 2
NCT07646678Not Yet Recruiting
Phase 2
A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaTakeda
NCT07648563
Interventional Study on the Effects of Forest Therapy in Fibromyalgia PatientsAzienda USL Toscana Nord OvestNot Yet RecruitingNot Applicable
NCT07648563Not Yet Recruiting
Not Applicable
Interventional Study on the Effects of Forest Therapy in Fibromyalgia PatientsAzienda USL Toscana Nord...
Result Breakdown
Not yet recruiting12 (60%)
Completed6 (30%)
Recruiting2 (10%)
not_applicable11 (55%)
Phase 25 (25%)
Not Specified3 (15%)
Phase 11 (5%)